Table 1 Characteristics of the Study Sample, including Demographic Characteristics and Baseline Data for the Study Measures (n = 145)
Variable Name | Q1 (1stquartile) | Q2 (median) | Q3 (3rdquartile) | Mean (SD) | N (%) |
|---|---|---|---|---|---|
Sex (F) | Â | Â | Â | Â | 84.0 (51.2) |
Age (in years) | 51.0 | 60.0 | 68.8 | 59.2 (13.2) | Â |
Education (in years) | 12.0 | 15.0 | 17.0 | 14.9 (3.3) | Â |
Melanoma stage | |||||
 0 (In situ) |  |  |  |  | 27.0 (16.5) |
 1 |  |  |  |  | 83.0 (50.6) |
 2 |  |  |  |  | 36.0 (22.0) |
 3 |  |  |  |  | 10.0 (6.1) |
 4 |  |  |  |  | 5.0 (3.0) |
 Missing |  |  |  |  | 3.0 (1.8) |
Melanoma knowledge | 0.7 | 0.8 | 1.0 | 0.8 (0.2) | Â |
SSE self-efficacy | 1.8 | 2.0 | 2.4 | 2.0 (0.5) | Â |
SSE intentions | 4.0 | 5.0 | 5 | 4.4 (0.9) | Â |
SCI | 1.4 | 1.8 | 2.4 | 2.0 (0.8) | Â |
PHQ-4 | 0.0 | 0.3 | 0.9 | 0.5 (0.8) | Â |
FKV-2 | 3.5 | 4.0 | 4.0 | 3.6 (0.5) | Â |
heiQ | 2.0 | 2.4 | 3.0 | 2.3 (0.6) | Â |
Comprehensive SSE (Range 0–4) | |||||
 3-month (n = 145) | 2.0 | 3.0 | 3.2 | 2.7 (1.1) |  |
 12-month (n = 130) | 1.8 | 3.0 | 3.4 | 2.6 (1.2) |  |
 24-month (n = 101) | 1.4 | 2.4 | 3.1 | 2.4 (1.2) |  |
Optimal SSE | |||||
 3-month (n = 145) |  |  |  |  | 85.0 (58.6) |
 12-month (n = 130) |  |  |  |  | 60.0 (46.2) |
 24-month (n = 101) |  |  |  |  | 34.0 (33.7) |